… explore serological responses to SARS-CoV-2 vaccination in … neutralization potential of
anti-SARS-CoV-2 antibodies were … We report, for the first time, that anti-SARS-CoV-2 vaccination…

… This paper focuses on the mechanism of CS induced by the SARS-CoV-2 virus and its
clinical manifestations, and reviews the recently reported immunotherapies for cytokine storm, …

… in tumors to discover potential small molecule inhibitors of AXL for preventing the entry of …
suppress viremia for passive immunotherapy is considered to be a promising option for anti-…

… infectivity of SARS CoV-2 appears to be mediated by the virus’s S-spike protein and CoV-2…
Because of comprehensive quality controls instituted by the manufacturer, it was discovered …

… for vaccination against infectious diseases following the SARS-CoV2 pandemic (1)…
immunotherapy, offering a broad range of RNA-based therapeutic strategies (2, 3). Since its …

… Comparing baseline and post-ICB, our results demonstrated that anti-PD-1/L1 immunotherapy
had no significant influence on SARS-CoV-2 SP antibody titers or T cell responses in a …

… the last few decades, the SARS-CoV-2 pandemic is now expected to … Thus, the development
of new cancer immunotherapies has … a brief history of immunotherapy discoveries and new …

… immunotherapy against SARS-CoV-2 infections and prevent future pandemic outbreaks. …
and experimentally confirmed epitopes between SARS-CoV and SARS-CoV-2 were chosen in …

… East respiratory syndrome coronavirus (MERS-CoV), such as … Whereas the trials on
SARS-CoV-2 genome-based specific … and those based on immunotherapy approaches either …

… bulk TCR datasets from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected …
to SARS-CoV-2 and demonstrate the utility of the reverse epitope discovery approach. …